GoHealth, Inc. Earnings Per Share Disclosure
| Twelve months ended Dec. 31, | ||||||||||||||||||||
| (in thousands, except per share amounts) | 2024 | 2023 | 2022 | |||||||||||||||||
| Numerator: | ||||||||||||||||||||
| Net loss | $ | (7,319) | $ | (151,270) | $ | (376,384) | ||||||||||||||
Less: Net loss attributable to non-controlling interests | (4,391) | (88,013) | (227,678) | |||||||||||||||||
| Net loss attributable to GoHealth, Inc. | (2,928) | (63,257) | (148,706) | |||||||||||||||||
Less: Dividends paid on redeemable convertible preferred stock | 3,661 | 3,566 | 943 | |||||||||||||||||
| Net loss attributable to common stockholders | (6,589) | (66,823) | (149,649) | |||||||||||||||||
| Denominator: | ||||||||||||||||||||
Weighted-average shares of Class A common stock outstanding—basic and diluted | 9,980 | 9,292 | 8,445 | |||||||||||||||||
| Net loss per share of Class A common stock—basic and diluted | $ | (0.66) | $ | (7.19) | $ | (17.72) | ||||||||||||||
Dec. 31, | ||||||||||||||||||||
| (in thousands) | 2024 | 2023 | 2022 | |||||||||||||||||
Equity awards | 2,488 | 1,973 | 1,534 | |||||||||||||||||
Redeemable convertible preferred stock | 3,989 | 3,873 | 3,855 | |||||||||||||||||
| Class B common stock | 12,711 | 12,814 | 13,054 | |||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Feb 27, 2025 | Showing above |
| 2023 | Mar 14, 2024 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.